69656-0103 Zejula - CanMED: NDC

Product NDC:

69656-0103

Brand Name:

Zejula

Generic Name:

Niraparib

Dosage Form Name:

Capsule

Administration Route:

Oral

Substances:

Name: Niraparib

Strength: 100.0

Unit: mg/1

Packages:

Code: 69656-0103-30

Description: 30 CAPSULE in 1 BOTTLE (69656-103-30)

Effective Date: July 1, 2018

Discontinued: Aug. 31, 2024

Code: 69656-0103-61

Description: 30 CAPSULE in 1 BOTTLE (69656-103-61)

Effective Date: July 1, 2020

Discontinued: Aug. 31, 2024

Code: 69656-0103-90

Description: 90 CAPSULE in 1 BOTTLE (69656-103-90)

Effective Date: March 27, 2017

Discontinued: May 31, 2022

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

PARP

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox